Figure 7

(a–f) Role of GLUT1 in VEGF-induced MC FN production. (a) Primary culture mouse MCs with the C57BL6 background were studied in culture with and without VEGF-A165 peptide (2 ng/ml) for 48 h. VEGF-A165 stimulated a two-fold increase in MC GLUT1 protein. (b) Graph of western blot data from MCs treated with VEGF. **P<0.05, n=4 in each group). (c) Graph of 3H2-deoxyglucose (DOG) uptake rates in cultured MCs treated with or without VEGF-A165 2 ng/ml for 48 h, **P<0.05 for VEGF-A165-treated cells vs controls, n=4 samples per group. The glucose uptake rate increased 3.6-fold in response to treatment with VEGF-A165. (d) FN protein increased 3.3-fold in response to the VEGF-A165 treatment, n=3 in each group. (e) In comparison, FN increased only 1.6-fold in cultured MCs from antisense-GLUT1 transgenic mice in response to the 2 ng/ml VEGF-A165 treatment for 48 h. (f) Graph of western blot data from MCs isolated from normal and antisense-GLUT1 transgenic mice, treated with VEGF. *P<0.01 and **P<0.05 vs controls.